Buy Full Version
"Implantable Medical Devices Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Implantable Medical Devices Market by Product (Orthopedic Implants, Dental Implants, Breast Implants, Cardiovascular Implants, Intraocular Lens, and Other Implants) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Update Available On-Demand

Medical Devices & Supplies	LI_16492	Pages: 208	Dec 2016 \| 7560 Views
Author(s) : Deepa Tatkare	Tables: 48	Charts: 118	Formats*:

Implantable Medical Devices Market was valued at $72,265 million, and is expected to reach $116,300 million by 2022, supported by a CAGR of 7.1%. An implant is a medical device, which is used to replace or support any damaged body organs, improve the functioning of body organs, or treat defects in normal body functions. These can be surgically implanted either permanently or temporarily in the human body, and can be removed when dispensable. These implantable devices comprise bones, tissues, skin, ceramics, metals, plastics, and other natural materials. The report analyzes the implantable medical devices market based on product and geography.

Global Implantable Medical Devices Market Segmentation

Get more information on this report : Request Sample Pages

Segment Review

According to the AMR analysis, the other implants market, including neurostimulators, orthobiologics, trauma & craniomaxillofacial implants, glaucoma implants, and facial implants, has the largest scope of applications for implantable devices, owing to rise in consumer awareness, innovative technological advancements, increase in incidence of neurological disorders among geriatric population, upsurge in FDA approvals for clinical trials, spiraling development of advanced implantable devices, and improved clinical outcomes.

The orthopedic implants segment bagged the largest market in terms of the total shares in global implantable medical devices market in 2015, due to rise in incidence of obesity and osteoporosis-related fractures. Furthermore, the number of patients opting for orthopedic implant surgeries have increased among in the age group of under 55 years to over 80 years. Moreover, increase in awareness about the benefits of such surgeries on the quality of life has fueled the adoption of these devices, especially in developing countries such as India and China. In addition, improvement of healthcare infrastructure in the developing countries has boosted the growth of the orthopedic implants market. New technologies, such as patient-specific implants, especially in knee arthroplasty, using 3D technology and sculptural CAD are being developed, which have numerous benefits over off-the-shelf implants.

The other implants market is estimated to generated output of 49,239 thousand units by 2019 at a CAGR of 14.8% from 2016 to 2022. This is due to the growth of the neurostimulation, orthobiologics, trauma & craniomaxillofacial, and facial implants segments. The neurostimulation segment has witnessed significant growth in the recent years, owing to innovative technological advancements, increase in incidence of neurological disorders among geriatric population, launch of cost-effective products, rise in consumer awareness, and growth in the number of regulatory approvals for these devices. In addition, the sales of orthobiologics has increased due to increase in cases related to sport injuries, accidents, ageing population and rise in awareness & preference among patients & surgeons. Similarly, the trauma & craniomaxillofacial implants market is driven by factors such as increase in the number of road and sports accidents every year, susceptibility of geriatric population to fractures, technological improvements such as use of robotic arm to assist CMF surgery, and introduction of bioabsorbable implants for cranial fixation. A similar trend was observed in the facial implants segment due to the development of 3D printed implants, hyaluronic acid facial fillers, and injectable implant treatment procedures.

The report provides comprehensive analyses of the key players such as Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., CONMED Corporation, Globus Medical, Inc., Integra Lifesciences Holdings Corporation, Johnson & Johnson, LivaNova PLC, Medtronic plc, NuVasive, Inc., Smith & Nephew plc, St. Jude Medical, Inc., Institut Straumann AG., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.,The other players in the value chain include Dentsply Sirona Inc., GC Aesthetics plc, Allergan Inc., Sientra Inc., Danaher Corporation, 3M Company, Polytech Health & Aesthetics GmbH, B. Braun Melsungen AG, Elixir Medical Corporation, Microport Scientific Corporation, STENTYS S.A., and Terumo Corporation. These players have not been profiled in the report, but can be included on request.

KEY BENEFITS

The study provides an in-depth analysis of the world implantable medical devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis for the period of 2014-2022 to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the global implantable medical devices market helps in understanding the various types of devices used for the treatment of chronic diseases and other related cardiac conditions.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.

Implantable Medical Devices Market Segmentaion

The global implantable medical devices market is segmented based on product type and geography.

By Product

Orthopedic Implants
- Spinal Implants
- Reconstructive Joint Replacement
Dental Implants
Breast Implants
Cardiovascular Implants
Intraocular Lens
Other Implants

By Region

North America
- U.S.
- Canada
- Mexic
Europe
- Germany
- UK
- France
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

CHAPTER 1. INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3. MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. Porters five forces analysis

3.3.1. Bargaining power of the suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. High intensity of rivalry
3.3.5. Threat of substitutes

3.4. Top Player Positioning, 2015
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Growing elderly population and rise in prevalence of chronic diseases
3.5.1.2. Technological advancements in the field of implantable medical devices
3.5.1.3. Global rise in acceptance of implantable medical devices
3.5.1.4. Improvement of healthcare infrastructure in developing countries
3.5.1.5. Better insurance and reimbursement
3.5.1.6. Increasing government focus on funding R&D initiatives
3.5.1.7. Rising number of FDA approvals for performing clinical trials to benefit the market

3.5.2. Restraints

3.5.2.1. High cost of treatment associated with implantable medical devices
3.5.2.2. Stringent approval process as these are highly specialized devices

3.5.3. Opportunities

3.5.3.1. Huge market opportunities in the APAC region and developing countries
3.5.3.2. Increasing awareness amongst patients and increasing preference for a better quality of life
3.5.3.3. Increase in development of minimally invasive and non-surgical procedures

CHAPTER 4. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Orthopedic implants

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Reconstructive joint replacements market size and forecast
4.2.5. Spinal implants market size and forecast

4.3. Cardiovascular implants

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. Intraocular lenses

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. Dental implants

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. Breast implants

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. Other implants

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

CHAPTER 5. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. North America

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S. market size and forecast
5.2.5. Canada market size and forecast
5.2.6. Mexico market size and forecast

5.3. Europe

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany market size and forecast
5.3.5. France market size and forecast
5.3.6. UK market size and forecast
5.3.7. Rest of Europe market size and forecast

5.4. Asia-Pacific

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan market size and forecast
5.4.5. China market size and forecast
5.4.6. India market size and forecast
5.4.7. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Latin America market size and forecast
5.5.5. Middle East market size and forecast
5.5.6. Africa market size and forecast

CHAPTER 6. COMPANY PROFILES

6.1. Abbott Laboratories

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves & developments
6.1.5. SWOT analysis

6.2. Biotronik SE & Co. KG

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Key strategic moves & developments
6.2.4. SWOT analysis

6.3. Boston Scientific Corporation

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves & developments
6.3.5. SWOT analysis

6.4. C. R. Bard, Inc.

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves & developments
6.4.5. SWOT analysis

6.5. Cardinal Health, Inc.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments
6.5.5. SWOT analysis

6.6. Conmed Corporation

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. SWOT analysis

6.7. Globus Medical, Inc.

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.7.5. SWOT analysis

6.8. Integra Lifesciences Holdings Corporation

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves & developments
6.8.5. SWOT analysis

6.9. Johnson & Johnson

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves & developments
6.9.5. SWOT analysis

6.10. LivaNova PLC

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves & developments
6.10.5. SWOT analysis

6.11. Medtronic plc

6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves & developments
6.11.5. SWOT analysis

6.12. Nuvasive, Inc.

6.12.1. Company overview
6.12.2. Operating business segments
6.12.3. Business performance
6.12.4. Key strategic moves & developments
6.12.5. SWOT analysis

6.13. Smith & Nephew Plc

6.13.1. Company overview
6.13.2. Operating business segments
6.13.3. Business performance
6.13.4. Key strategic moves & developments
6.13.5. SWOT analysis

6.14. St. Jude Medical, Inc.

6.14.1. Company overview
6.14.2. Operating business segments
6.14.3. Business performance
6.14.4. Key strategic moves & developments
6.14.5. SWOT analysis

6.15. Institut Straumann AG.

6.15.1. Company overview
6.15.2. Business performance
6.15.3. Key strategic moves & developments
6.15.4. SWOT analysis

6.16. Stryker Corporation

6.16.1. Company overview
6.16.2. Operating business segments
6.16.3. Business performance
6.16.4. Key strategic moves & developments
6.16.5. SWOT analysis

6.17. Wright Medical Group N.V.

6.17.1. Company overview
6.17.2. Operating business segments
6.17.3. Business performance
6.17.4. Key strategic moves & developments
6.17.5. SWOT analysis

6.18. Zimmer Biomet Holdings, Inc.

6.18.1. Company overview
6.18.2. Operating business segments
6.18.3. Business performance
6.18.4. Key strategic moves & developments
6.18.5. SWOT analysis

List of Tables

TABLE 1. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 2. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT (THOUSAND UNITS), 2014-2022
TABLE 3. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 4. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 5. WORLD ORTHOPEDIC IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 6. WORLD RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. WORLD SPINAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. WORLD CARDIOVASCULAR IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9. WORLD INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 10. WORLD DENTAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. WORLD BREAST IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12. WORLD OTHER IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 13. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 14. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 15. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 16. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 17. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 18. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 19. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 20. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 21. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 22. ABBOTT: COMPANY SNAPSHOT
TABLE 23. ABBOTT: OPERATING SEGMENTS
TABLE 24. BIOTRONIK- COMPANY SNAPSHOT
TABLE 25. BIOTRONIK: OPERATING SEGMENTS
TABLE 26. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 27. C. R. BARD- COMPANY SNAPSHOT
TABLE 28. CARDINAL HEALTH- COMPANY SNAPSHOT
TABLE 29. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 30. CONMED - COMPANY SNAPSHOT
TABLE 31. CONMED - PRODUCT CATEGORY
TABLE 32. GLOBUS MEDICAL- COMPANY SNAPSHOT
TABLE 33. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 34. INTEGRA LIFESCIENCES - COMPANY SNAPSHOT
TABLE 35. INTEGRA LIFESCIENCES: PRODUCT CATEGORY
TABLE 36. J &J: COMPANY SNAPSHOT
TABLE 37. LIVANOVA: - COMPANY SNAPSHOT
TABLE 38. LIVANOVA: OPERATING SEGMENTS
TABLE 39. MEDTRONIC - COMPANY SNAPSHOT
TABLE 40. MEDTRONIC: OPERATING SEGMENTS
TABLE 41. NUVASIVE- COMPANY SNAPSHOT
TABLE 42. NUVASIVE- OPERATING SEGMENTS
TABLE 43. SMITH & NEPHEW - COMPANY SNAPSHOT
TABLE 44. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 45. ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 46. INSTITUT STRAUMANN: COMPANY SNAPSHOT
TABLE 47. STRYKER - COMPANY SNAPSHOT
TABLE 48. ZIMMER BIOMET- COMPANY SNAPSHOT

List of Figures

FIGURE 1. IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN WORLD IMPLANTABLE MEDICAL DEVICES MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. PORTERS FIVE FORCES ANALYSIS
FIGURE 9. TOP PLAYER POSITIONING, 2015
FIGURE 10. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 11. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT (THOUSAND UNITS), 2014-2022
FIGURE 12. WORLD ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 13. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
FIGURE 14. WORLD ORTHOPEDIC IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 15. RECONSTRUCTIVE JOINT REPLACEMENTS MARKET ($MILLION), 2014-2022
FIGURE 16. WORLD RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 17. SPINAL IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 18. WORLD SPINAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 19. WORLD CARDIOVASCULAR IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 20. WORLD CARDIOVASCULAR IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 21. WORLD INTRAOCULAR LENS MARKET ($MILLION), 2014-2022
FIGURE 22. WORLD INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 23. WORLD DENTAL IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 24. WORLD DENTAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 25. WORLD BREAST IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 26. WORLD BREAST IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 27. WORLD OTHER IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 28. WORLD OTHER IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 29. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 30. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 31. U.S. IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 32. CANADA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 33. MEXICO IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 34. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 35. GERMANY IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 36. FRANCE IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 37. U.K. IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 38. REST OF EUROPE IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 39. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 40. JAPAN IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 41. CHINA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 42. INDIA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 43. REST OF ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 44. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 45. LATIN AMERICA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 46. MIDDLE EAST IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 47. AFRICA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 48. ABBOTT: REVENUE ($MILLION), 2013-2015
FIGURE 49. ABBOTT: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 50. ABBOTT: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 51. ABBOTT: SWOT ANALYSIS
FIGURE 52. BIOTRONIK- SWOT ANALYSIS
FIGURE 53. BOSTON SCIENTIFIC: REVENUE ($MILLION), 2013-2015
FIGURE 54. BOSTON SCIENTIFIC: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 55. BOSTON SCIENTIFIC: REVENUE, BY SUBSEGMENT (%), 2015
FIGURE 56. BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 57. BOSTON SCIENTIFIC: SWOT ANALYSIS
FIGURE 58. C. R. BARD: REVENUE ($MILLION), 2013-2015
FIGURE 59. C. R. BARD: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 60. C. R. BARD: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 61. C. R. BARD - SWOT ANALYSIS
FIGURE 62. CARDINAL HEALTH: REVENUE ($MILLION), 2013-2015
FIGURE 63. CARDINAL HEALTH: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 64. CARDINAL HEALTH: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 65. CARDINAL HEALTH: SWOT ANALYSIS
FIGURE 66. CONMED: REVENUE ($MILLION), 2013-2015
FIGURE 67. CONMED: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 68. CONMED: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 69. CONMED: SWOT ANALYSIS
FIGURE 70. GLOBUS MEDICAL: NET SALES ($MILLION), 2013-2015
FIGURE 71. GLOBUS MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY (%), 2015
FIGURE 72. GLOBUS MEDICAL: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 73. GLOBUS MEDICAL: SWOT ANALYSIS
FIGURE 74. INTEGRA LIFESCIENCES: REVENUE ($MILLION), 2013-2015
FIGURE 75. INTEGRA LIFESCIENCES: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 76. INTEGRA LIFESCIENCES: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 77. INTEGRA LIFESCIENCES - SWOT ANALYSIS
FIGURE 78. J&J: REVENUE ($MILLION), 2013-2015
FIGURE 79. J&J: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 80. J&J: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 81. J & J: SWOT ANALYSIS
FIGURE 82. LIVANOVA: NET SALES ($MILLION), 2013-2015
FIGURE 83. LIVANOVA: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 84. LIVANOVA: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 85. LIVANOVA: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 86. LIVANOVA- SWOT ANALYSIS
FIGURE 87. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 88. MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 89. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 90. MEDTRONIC: SWOT ANALYSIS
FIGURE 91. NUVASIVE: REVENUE ($MILLION), 2013-2015
FIGURE 92. NUVASIVE: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 93. NUVASIVE: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 94. NUVASIVE: SWOT ANALYSIS
FIGURE 95. SMITH & NEPHEW: REVENUE ($MILLION), 2013-2015
FIGURE 96. SMITH & NEPHEW: REVENUE, BY PRODUCT TYPE (%), 2015
FIGURE 97. SMITH & NEPHEW: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 98. SMITH & NEPHEW: SWOT ANALYSIS
FIGURE 99. ST. JUDE MEDICAL: NET SALES ($MILLION), 2013-2015
FIGURE 100. ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY (%), 2015
FIGURE 101. ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 102. ST. JUDE MEDICAL - SWOT ANALYSIS
FIGURE 103. STRAUMANN: REVENUE ($MILLION), 2013-2015
FIGURE 104. STRAUMANN: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 105. STRAUMANN: SWOT ANALYSIS
FIGURE 106. STRYKER: REVENUE ($MILLION), 2013-2015
FIGURE 107. STRYKER: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 108. STRYKER: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 109. STRYKER - SWOT ANALYSIS
FIGURE 110. WRIGHT- COMPANY SNAPSHOT
FIGURE 111. WRIGHT: REVENUE ($MILLION), 2013-2015
FIGURE 112. WRIGHT: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 113. WRIGHT: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 114. WRIGHT- SWOT ANALYSIS
FIGURE 115. ZIMMER BIOMET: REVENUE ($MILLION), 2013-2015
FIGURE 116. ZIMMER BIOMET: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 117. ZIMMER BIOMET: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 118. ZIMMER BIOMET- SWOT ANALYSIS

The adoption of medical implants, such as cardiac, orthopedic, dental, and breast implants is expected to increase in the near future due to high prevalence of chronic diseases and rise in geriatric population. The implantable medical devices market has piqued the interest of healthcare providers due to the benefits offered by these devices to monitor and treat clinical disorders. There have been remarkable technological advancements in medical implants to provide advanced treatment options for disease management. The Asia-Pacific and LAMEA regions are expected to offer lucrative opportunities to market players, as the markets in the developed nations are saturated with large number of implantable medical device providers.

The global market is driven by factors such as high incidence of chronic diseases, increase in geriatric population, technological advancements, rise in acceptance of medical implants, and improvement of healthcare infrastructure in emerging nations. However, high cost of treatment associated with medical implants, reimbursement issues, and stringent regulatory policies for product approval hamper the market growth. Increase in incidence of obesity and rise in osteoporosis-related fractures amongst all age groups fuel the need for orthopedic interventions. In addition, medical implant manufacturers and distributors have focused on expanding in the emerging markets. Healthcare spending, prevalence of breast cancer cases and demand for high quality screening have offered new opportunities for the companies to gain additional shares in emerging markets.

At present, the orthopedic implants segment dominated the global implantable medical devices market in terms of volume and revenue, followed by the other implants segment. The emerging nations witnessed rapid increase in the shipments of these devices to improve their healthcare infrastructure. This is expected to offset challenging conditions in the mature markets such as North America and Europe. North America is expected to dominate the global implantable medical devices market during the forecast period, followed by Europe.

Online Only ~~$3,565~~ $3,137 Data Pack/Excel ~~$3,961~~ $3,486 Single User License ~~$5,540~~ $4,432 Five User License ~~$6,654~~ $4,991 Enterprise User License ~~$9,280~~ $6,496

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com